These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1028 related items for PubMed ID: 30165035
21. Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor. Warnecke-Eberz U, Chon SH, Hölscher AH, Drebber U, Bollschweiler E. Tumour Biol; 2015 Jun; 36(6):4643-53. PubMed ID: 25631748 [Abstract] [Full Text] [Related]
22. Downregulation of LAT1 expression suppresses cholangiocarcinoma cell invasion and migration. Janpipatkul K, Suksen K, Borwornpinyo S, Jearawiriyapaisarn N, Hongeng S, Piyachaturawat P, Chairoungdua A. Cell Signal; 2014 Aug; 26(8):1668-79. PubMed ID: 24726839 [Abstract] [Full Text] [Related]
23. Micro-RNA-130a-3p Regulates Gemcitabine Resistance via PPARG in Cholangiocarcinoma. Asukai K, Kawamoto K, Eguchi H, Konno M, Asai A, Iwagami Y, Yamada D, Asaoka T, Noda T, Wada H, Gotoh K, Nishida N, Satoh T, Doki Y, Mori M, Ishii H. Ann Surg Oncol; 2017 Aug; 24(8):2344-2352. PubMed ID: 28560603 [Abstract] [Full Text] [Related]
24. MORC2 promotes cell growth and metastasis in human cholangiocarcinoma and is negatively regulated by miR-186-5p. Liao G, Liu X, Wu D, Duan F, Xie X, Wen S, Li Y, Li S. Aging (Albany NY); 2019 Jun 09; 11(11):3639-3649. PubMed ID: 31180332 [Abstract] [Full Text] [Related]
25. Exosomal piRNA profiling revealed unique circulating piRNA signatures of cholangiocarcinoma and gallbladder carcinoma. Gu X, Wang C, Deng H, Qing C, Liu R, Liu S, Xue X. Acta Biochim Biophys Sin (Shanghai); 2020 May 26; 52(5):475-484. PubMed ID: 32369104 [Abstract] [Full Text] [Related]
26. Overexpression of miR-27a predicts poor prognosis and promotes the progression in cholangiocarcinoma. Liu Y, Liu X, Zhou Y, Liu T, Li J. Clin Exp Med; 2021 Feb 26; 21(1):121-128. PubMed ID: 32816152 [Abstract] [Full Text] [Related]
27. Dysregulation of microRNA in cholangiocarcinoma identified through a meta-analysis of microRNA profiling. Likhitrattanapisal S, Kumkate S, Ajawatanawong P, Wongprasert K, Tohtong R, Janvilisri T. World J Gastroenterol; 2020 Aug 07; 26(29):4356-4371. PubMed ID: 32848339 [Abstract] [Full Text] [Related]
28. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis. Zhang H, Zhu M, Shan X, Zhou X, Wang T, Zhang J, Tao J, Cheng W, Chen G, Li J, Liu P, Wang Q, Zhu W. Gene; 2019 Mar 01; 687():246-254. PubMed ID: 30458288 [Abstract] [Full Text] [Related]
29. MicroRNA-551b-3p inhibits tumour growth of human cholangiocarcinoma by targeting Cyclin D1. Chang W, Wang Y, Li W, Shi L, Geng Z. J Cell Mol Med; 2019 Aug 01; 23(8):4945-4954. PubMed ID: 31199052 [Abstract] [Full Text] [Related]
30. Yin Yang 1-induced LINC00667 up-regulates pyruvate dehydrogenase kinase 1 to promote proliferation, migration and invasion of cholangiocarcinoma cells by sponging miR-200c-3p. Li J, Guan C, Hu Z, Liu L, Su Z, Kang P, Jiang X, Cui Y. Hum Cell; 2021 Jan 01; 34(1):187-200. PubMed ID: 33040228 [Abstract] [Full Text] [Related]
31. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing. Jin X, Chen Y, Chen H, Fei S, Chen D, Cai X, Liu L, Lin B, Su H, Zhao L, Su M, Pan H, Shen L, Xie D, Xie C. Clin Cancer Res; 2017 Sep 01; 23(17):5311-5319. PubMed ID: 28606918 [Abstract] [Full Text] [Related]
32. Bioinformatics Analysis Identifies the Estrogen Receptor 1 (ESR1) Gene and hsa-miR-26a-5p as Potential Prognostic Biomarkers in Patients with Intrahepatic Cholangiocarcinoma. Qin X, Song Y. Med Sci Monit; 2020 May 21; 26():e921815. PubMed ID: 32435051 [Abstract] [Full Text] [Related]
33. Sirtuin7 has an oncogenic potential via promoting the growth of cholangiocarcinoma cells. Li W, Sun Z, Chen C, Wang L, Geng Z, Tao J. Biomed Pharmacother; 2018 Apr 21; 100():257-266. PubMed ID: 29438839 [Abstract] [Full Text] [Related]
34. MicroRNA-329-mediated PTTG1 downregulation inactivates the MAPK signaling pathway to suppress cell proliferation and tumor growth in cholangiocarcinoma. Hu ZG, Zheng CW, Su HZ, Zeng YL, Lin CJ, Guo ZY, Zhong FD, Yuan GD, He SQ. J Cell Biochem; 2019 Jun 21; 120(6):9964-9978. PubMed ID: 30582202 [Abstract] [Full Text] [Related]
35. Exosomal microRNAs as potential biomarkers for cancer cell migration and prognosis in hepatocellular carcinoma patient-derived cell models. Yu LX, Zhang BL, Yang Y, Wang MC, Lei GL, Gao Y, Liu H, Xiao CH, Xu JJ, Qin H, Xu XY, Chen ZS, Zhang DD, Li FG, Zhang SG, Liu R. Oncol Rep; 2019 Jan 21; 41(1):257-269. PubMed ID: 30542726 [Abstract] [Full Text] [Related]
36. Exosomal circ_0037104 derived from Hu-MSCs inhibits cholangiocarcinoma progression by sponging miR-620 and targeting AFAP1. Yuan Z, Xiong B, Liu L, Lu Y, Liu Y, Wang G, Qian Y, Diao B, Tu M. J Biochem Mol Toxicol; 2024 Feb 21; 38(2):e23656. PubMed ID: 38348717 [Abstract] [Full Text] [Related]
37. BMI1 promotes cholangiocarcinoma progression and correlates with antitumor immunity in an exosome-dependent manner. Liu Z, Hu C, Zheng L, Liu J, Li K, Li X, Wang Y, Mu W, Chen T, Shi A, Qiu B, Zhang X, Zhang Z, Xu Y. Cell Mol Life Sci; 2022 Aug 06; 79(9):469. PubMed ID: 35932322 [Abstract] [Full Text] [Related]
38. Epigenetic Silencing of miRNA-34a in Human Cholangiocarcinoma via EZH2 and DNA Methylation: Impact on Regulation of Notch Pathway. Kwon H, Song K, Han C, Zhang J, Lu L, Chen W, Wu T. Am J Pathol; 2017 Oct 06; 187(10):2288-2299. PubMed ID: 28923203 [Abstract] [Full Text] [Related]
39. E2F1-induced upregulation of long non-coding RNA LMCD1-AS1 facilitates cholangiocarcinoma cell progression by regulating miR-345-5p/COL6A3 pathway. Yu J, Zhang B, Zhang H, Qi Y, Wang Y, Wang W, Wang Y, Wang Y. Biochem Biophys Res Commun; 2019 Apr 30; 512(2):150-155. PubMed ID: 30876691 [Abstract] [Full Text] [Related]
40. Exosomal microRNA-23a-3p contributes to the progression of cholangiocarcinoma by interaction with Dynamin3. Ni Q, Zhang H, Shi X, Li X. Bioengineered; 2022 Mar 30; 13(3):6208-6221. PubMed ID: 35200104 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]